Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10424325rdf:typepubmed:Citationlld:pubmed
pubmed-article:10424325lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:10424325lifeskim:mentionsumls-concept:C0201734lld:lifeskim
pubmed-article:10424325lifeskim:mentionsumls-concept:C0939219lld:lifeskim
pubmed-article:10424325pubmed:issue4lld:pubmed
pubmed-article:10424325pubmed:dateCreated1999-9-8lld:pubmed
pubmed-article:10424325pubmed:abstractTextTo assess the magnitude of the putative effect of atovaquone on the pharmacokinetics of proguanil and to determine whether the pharmacokinetics of atovaquone are affected by concomitant administration of proguanil, with both drugs administered for 3 days to healthy adult volunteers.lld:pubmed
pubmed-article:10424325pubmed:languageenglld:pubmed
pubmed-article:10424325pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10424325pubmed:citationSubsetIMlld:pubmed
pubmed-article:10424325pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10424325pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10424325pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10424325pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10424325pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10424325pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10424325pubmed:statusMEDLINElld:pubmed
pubmed-article:10424325pubmed:monthJunlld:pubmed
pubmed-article:10424325pubmed:issn0031-6970lld:pubmed
pubmed-article:10424325pubmed:authorpubmed-author:GillotinCClld:pubmed
pubmed-article:10424325pubmed:authorpubmed-author:VeroneseLLlld:pubmed
pubmed-article:10424325pubmed:authorpubmed-author:MametJ PJPlld:pubmed
pubmed-article:10424325pubmed:issnTypePrintlld:pubmed
pubmed-article:10424325pubmed:volume55lld:pubmed
pubmed-article:10424325pubmed:ownerNLMlld:pubmed
pubmed-article:10424325pubmed:authorsCompleteYlld:pubmed
pubmed-article:10424325pubmed:pagination311-5lld:pubmed
pubmed-article:10424325pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:10424325pubmed:meshHeadingpubmed-meshheading:10424325...lld:pubmed
pubmed-article:10424325pubmed:meshHeadingpubmed-meshheading:10424325...lld:pubmed
pubmed-article:10424325pubmed:meshHeadingpubmed-meshheading:10424325...lld:pubmed
pubmed-article:10424325pubmed:meshHeadingpubmed-meshheading:10424325...lld:pubmed
pubmed-article:10424325pubmed:meshHeadingpubmed-meshheading:10424325...lld:pubmed
pubmed-article:10424325pubmed:meshHeadingpubmed-meshheading:10424325...lld:pubmed
pubmed-article:10424325pubmed:meshHeadingpubmed-meshheading:10424325...lld:pubmed
pubmed-article:10424325pubmed:meshHeadingpubmed-meshheading:10424325...lld:pubmed
pubmed-article:10424325pubmed:meshHeadingpubmed-meshheading:10424325...lld:pubmed
pubmed-article:10424325pubmed:meshHeadingpubmed-meshheading:10424325...lld:pubmed
pubmed-article:10424325pubmed:meshHeadingpubmed-meshheading:10424325...lld:pubmed
pubmed-article:10424325pubmed:meshHeadingpubmed-meshheading:10424325...lld:pubmed
pubmed-article:10424325pubmed:year1999lld:pubmed
pubmed-article:10424325pubmed:articleTitleLack of a pharmacokinetic interaction between atovaquone and proguanil.lld:pubmed
pubmed-article:10424325pubmed:affiliationLaboratoire Glaxo Wellcome, Pharmacologie Clinique, Marly-le-Roi, France. cg33250@glaxowellcome.co.uklld:pubmed
pubmed-article:10424325pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10424325pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10424325pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:10424325pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed